Coronary vasoconstrictor influence of angiotensin II is reduced in remodeled myocardium after myocardial infarction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 5, 2006, Pages

  Merkus, Daphne ^a   Haitsma, David B ^a   Sorop, Oana ^a   Boomsma, Frans ^a   De Beer, Vincent J ^a   Lamers, Jos M J ^b   Verdouw, Pieter D ^a   Duncker, Dirk J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Autonomic nervous system; Coronary circulation; Heart failure; Remodeling; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; IRBESARTAN; NEUROHORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD VESSEL TONE; CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY ARTERY LIGATION; CORONARY HEMODYNAMICS; DRUG INHIBITION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REST; RUNNING; SWINE; TREADMILL EXERCISE;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIPHENYL COMPOUNDS; BODY WEIGHT; CORONARY CIRCULATION; EXERCISE TEST; FEMALE; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; NOREPINEPHRINE; ORGAN SIZE; OXYGEN; PHYSICAL CONDITIONING, ANIMAL; SUS SCROFA; TETRAZOLES; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASOMOTOR SYSTEM;

EID: 33751195531     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00861.2005     Document Type: Article

References (41)

1. Batenburg WW, Garrelds IM, Bernasconi CC, Juillerat-Jeanneret L, van Kats JP, Saxena PR, and Danser AHJ. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation 109: 2296-2301, 2004.
2. 1 receptor blockers. Basic Res Cardiol 93, Suppl 2: 15-23, 1998.
3. 1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns. J Card Fail 4: 311-323, 1998.
4. 2-adrenergic blockade. Am J Physiol Heart Circ Physiol 256: H1148-H1155, 1989.
5. De Gasparo M, Catt KJ, Inagami T, Wright JW, and Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
6. Duncker DJ, Haitsma DB, Liem DA, Verdouw PD, and Merkus D. Exercise unmasks autonomic dysfunction in swine with a recent myocardial infarction. Cardiovasc Res 65: 889-896, 2005.
7. Duncker DJ and Merkus D. Acute adaptations of the coronary circulation to exercise. Cell Biochem Biophys 43: 17-36, 2005.
8. Duncker DJ, Saxena PR, and Verdouw PD. Systemic haemodynamic and beta-adrenoceptor antagonistic effects of bisoprolol in conscious pigs: a comparison with propranolol. Arch Int Pharmacodyn Ther 290: 54-63, 1987.
9. Duncker DJ, Stubenitsky R, and Verdouw PD. Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise: evidence for feed-forward beta-adrenergic control. Circ Res 82: 1312-1322, 1998.
10. Francis GS. Pathophysiology of chronic heart failure. Am J Med 110, Suppl 7A: 37S-46S, 2001.
11. Gorman MW, Farias M III, Richmond KN, Tune JD, and Feigl EO. Role of endothelin in α-adrenoceptor coronary vasoconstriction. Am J Physiol Heart Circ Physiol 288: H1937-H1942, 2005.
12. Haitsma DB, Bac D, Raja N, Boomsma F, Verdouw PD, and Duncker DJ. Minimal impairment of myocardial blood flow responses to exercise in the remodeled left ventricle early after myocardial infarction, despite significant hemodynamic and neurohumoral alterations. Cardiovasc Res 52: 417-428, 2001.
13. Haitsma DB, Merkus D, Vermeulen J, Verdouw PD, and Duncker DJ. Nitric oxide production is maintained in exercising swine with chronic left ventricular dysfunction. Am J Physiol Heart Circ Physiol 282: H2198-H2209, 2002.
14. + channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res 82: 346-359, 1998.
15. Kalkman EA, Bilgin YM, van Haren P, van Suylen RJ, Saxena PR, and Schoemaker RG. Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding. Cardiovasc Res 32: 1088-1095, 1996.
16. Karam R, Healy BP, and Wicker P. Coronary reserve is depressed in postmyocardial infarction reactive cardiac hypertrophy. Circulation 81: 238-246, 1990.
17. Kawai H, Stevens SY, and Liang CS. Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure. Am J Physiol Heart Circ Physiol 279: H3012-H3019, 2000.
18. Lameris TW, de Zeeuw S, Duncker DJ, Alberts G, Boomsma F, Verdouw PD, and van den Meiracker AH. Exogenous angiotensin II does not facilitate norepinephrine release in the heart. Hypertension 40: 491-497, 2002.
19. Lefroy DC, Wharton J, Crake T, Knock GA, Rutherford RA, Suzuki T, Morgan K, Polak JM, and Poole-Wilson PA. Regional changes in angiotensin II receptor density after experimental myocardial infarction. J Mol Cell Cardiol 28: 429-440, 1996.
20. 2-receptor subtypes in hypertrophied rat hearts. Am J Physiol Heart Circ Physiol 267: H844-H852, 1994.
21. Merkus D, Duncker DJ, and Chilian WM. Metabolic regulation of coronary vascular tone: role of endothelin-1. Am J Physiol Heart Circ Physiol 283: H1915-H1921, 2002.
22. Merkus D, Houweling B, Mirza A, Boomsma F, van den Meiracker AH, and Duncker DJ. Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation. Cardiovasc Res 59: 745-754, 2003.
23. Merkus D, Houweling B, van den Meiracker AH, Boomsma F, and Duncker DJ. Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction. Am J Physiol Heart Circ Physiol 288: H871-H880, 2005.
24. Oikawa Y, Maehara K, Saito T, Tamagawa K, and Maruyama Y. Attenuation of angiotensin II-mediated coronary vasoconstriction and vasodilatory action of angiotensin-converting enzyme inhibitor in pacing-induced heart failure in dogs. J Am Coll Cardiol 38: 1188-1194, 2001.
25. Prasad A, Halcox JP, Waclawiw MA, and Quyyumi AA. Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis. J Am Coll Cardiol 38: 1089-1095, 2001.
26. Richard V, Berdeaux A, and Giudicelli JF. Systemic and coronary effects of the angiotensin II receptor antagonist EXP3174 in dogs. J Cardiovasc Pharmacol 22: 52-57, 1993.
27. Rigol M, Heras M, Solanes N, Epelde F, Roig E, Perez-Villa F, Roque M, and Sanz G. Enalaprilat, losartan and LU 135252 in coronary blood flow regulation. Eur J Clin Invest 33: 363-369, 2003.
28. Schaper W, Remijsen P, and Xhonneux R. The size of myocardial infarction after experimental coronary artery ligation. Z Kreislaufforsch 58: 904-909, 1969.
29. 2 receptor-mediated vasodilation in the heart: effect of myocardial infarction. Am J Physiol Heart Circ Physiol 281: H2590-H2596, 2001.
30. Stebbins CL and Symons JD. Role of angiotensin II in hemodynamic responses to dynamic exercise in miniswine. J Appl Physiol 78: 185-190, 1995.
31. Sudhir K, MacGregor JS, Gupta M, Barbant SD, Redberg R, Yock PG, and Chatterjee K. Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies. Circulation 87: 931-938, 1993.
32. Symons JD and Stebbins CL. Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin. J Cardiovasc Pharmacol 28: 223-231, 1996.
33. + channels, inhibits coronary vasodilation induced by angiotensin II-receptor antagonists. J Cardiovasc Pharmacol 30: 313-319, 1997.
34. Teisman AC, Westerink BH, van Veldhuisen DJ, Scholtens E, de Zeeuw D, and van Gilst WH. Direct interaction between the sympathetic and renin-angiotensin system in myocardial tissue: a microdialysis study in anaesthetised rats. J Auton Nerv Syst 78: 117-121, 2000.
35. Tune JD, Gorman MW, and Feigl EO. Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol 97: 404-415, 2004.
36. Van der Velden J, Merkus D, Klarenbeek BR, James AT, Boontje NM, Dekkers DH, Stienen GJ, Lamers JM, and Duncker DJ. Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction. Circ Res 95: e85-e95, 2004.
37. Van Kats JP, Duncker DJ, Haitsma DB, Schuijt MP, Niebuur R, Stubenitsky R, Boomsma F, Schalekamp MA, Verdouw PD, and Danser AH. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 102: 1556-1563, 2000.
38. Wackenfors A, Emilson M, Ingemansson R, Edvinsson L, and Malmsjo M. Ischemic heart disease down-regulates angiotensin type 1 receptor mRNA in human coronary arteries. Eur J Pharmacol 503: 147-153, 2004.
39. 2 receptors in modulating coronary microvascular function. Circ Res 92: 322-329, 2003.
40. 1 receptors. Am J Physiol Heart Circ Physiol 288: H2154-H2162, 2005.
41. Zhang J, Wilke N, Wang Y, Zhang Y, Wang C, Eijgelshoven MH, Cho YK, Murakami Y, Ugurbil K, Bache RJ, and From AH. Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model. MRI and 31 P-MRS study. Circulation 94: 1089-1100, 1996.